Virginia Department of Health officials are continuing to investigate an E. coli outbreak at a popular Boy Scouts camp in the Blue Ridge Mountains that has affected 17 people so far.

The officials began receiving reports of sick children Sunday, when boys from about 70 troops and some adults returned home after a week at the Goshen Scout Reservation near Lexington, VA. Most of the scouts are from northern Virginia, and one of the confirmed cases involves a Maryland adult

Women ages 19 through 64 should be routinely tested for HIV. That's the new recommendation released Thursday by the American College of Obstetricians and Gynecologists (ACOG).

In a formal committee opinion published in the August issue of Obstetrics and Gynecology, the college said obstetrician-gynecologists play an important role in promoting HIV screening for their patients under the recommendations by the U.S. Centers for Disease Control and Prevention (CDC)

President George Bush on Wednesday approved $48 billion for fighting AIDS, malaria, and tuberculosis around the world for next five years.

The amount authorized for the President's Emergency Plan for AIDS Relief (PEPFAR), the successful U.S. global AIDS program, is $18 billion more than what Bush had requested. The measure will triple funding for these three diseases

While there have been significant gains in preventing new HIV infections in different countries, the epidemic is far from over in any part of the world, according to a United Nations report.

The 2008 report on the global AIDS epidemic, produced by the Joint U.N .Program on HIV/AIDS (UNAIDS), released on Tuesday, is the most comprehensive review of the epidemic to date with 147 countries reporting data on HIV

Outside medical experts for the Food and Drug Administration (FDA) on Tuesday recommended approval of Roche Holding AG's drug Actemra to treat moderate to severe rheumatoid arthritis.

The drug is more effective at reducing symptoms of rheumatoid arthritis than existing biologic agents, which are dominated by a type of drug known as anti-TNFs. The new drug will target the drug for patients who failed anti-TNFs, such as Johnson & Johnson's drug Remicade and Abbott Laboratories' Humira, DowJones reported